Laurus Generics Inc

General

Total Cases13
Active Cases4
Patents--
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
07/18/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,096,918. (Attachments: # 1 Consent Judgment (redacted version))(nms) (Entered: 07/18/2024)
07/12/24
REDACTED VERSION of 266 Consent Judgment, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 7/14/2024 (nms). (Entered: 07/12/2024)
07/12/24
REDACTED VERSION of 265 Proposed Consent Judgment, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 7/14/2024 (nms). (Entered: 07/12/2024)
07/08/24
[SEALED] Consent Judgment and Order of Injunction. Signed by Judge Richard G. Andrews on 7/8/2024.*This order has been emailed to local counsel. Associated Cases: 1:20-md-02930-RGA, 1:21-cv-01330-RGA, 1:21-cv-01794-RGA(nms) (Entered: 07/08/2024)
07/08/24
CASE CLOSED per entry of D.I. 266 . (nms) (Entered: 07/08/2024)
07/05/24
[SEALED] PROPOSED Consent Judgment and Order of Injunction, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 7/7/2024 (nms). (Entered: 07/05/2024)
06/28/24
REDACTED VERSION of 263 Consent Judgment, by Hetero Labs Limited, Hetero Labs Limited Unit III, Hetero USA Inc., Hetero USA Inc.,. (Taylor, Daniel) Modified on 6/28/2024 (nms). (Entered: 06/28/2024)
06/21/24
[SEALED] CONSENT JUDGMENT and Order of Injunction. Signed by Judge Richard G. Andrews on 6/21/2024.*This filing has been emailed to local counsel. Associated Cases: 1:20-md-02930-RGA, 1:21-cv-01330-RGA, 1:21-cv-01760-RGA(nms) (Entered: 06/21/2024)
06/20/24
Sur-Surreply Post-Trial Brief on the invalidity of U.S. Patent No. 11,058,667, by Torrent Pharma Inc., Torrent Pharmaceuticals Ltd.. (Taylor, Daniel) Modified on 6/20/2024 (nms). (Entered: 06/20/2024)
06/12/24
REDACTED VERSION of 259 Proposed Consent Judgment, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 6/12/2024 (nms). (Entered: 06/12/2024)